RBC Capital Starts atai Life Sciences N.V. (ATAI) at Sector Perform

RBC Capital analyst Brian Abrahams initiates coverage on atai Life Sciences N.V. (NASDAQ: ATAI) with a Sector Perform rating and a price target of $19.00.

The analyst comments "Initiating coverage of ATAI at Sector Perform, Speculative Risk. We believe the company's valuation appropriately credits its broad assembly of promising assets and future leadership potential in an emerging neuropsych space, and see longer-term upside opportunity upon success. In the near term, we would expect in-line trade as the company executes on its early clinical development and in-licensing strategies, until the programs mature further and more de-risking data emerge."

For an analyst ratings summary and ratings history on atai Life Sciences N.V. click here. For more ratings news on atai Life Sciences N.V. click here.

Shares of atai Life Sciences N.V. closed at $19.00 yesterday.

You May Also Be Interested In

• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
• Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
• Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)